We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 09 JANUARY 2017
Merk's Patent Valid But Teva's Nasonex Generic Non-Infringing
Khurana & Khurana, Advocates and IP Attorneys
Anhydrous Mometasone Furoate ("MFA") was earlier patented by Merck in the early 1980s. MFA and MFM are the polymorphs. On July 3, 2014, plaintiff i.e. Merck brought this action alleging infringement.
United StatesIntellectual Property






